Ann: Trading Halt, page-14

Agree with you ToH, but like many other long term holders who have participated in every capital raising over the last 10 years, I am getting weary. 18 months ago I thought at 7.5 cents a share ( 1 for 20 rights issue) that was it. At the time we were told this cash should be sufficient to see us through until 2H 2015 funding us through key milestones;
1. interim and final phase 2 data and a end of phase 2 meeting with FDA for smoking cesstion.
2. completion of phase 2 trial analysis for lupus.
3.interim data for oral asthma trial.
Jump to March 2015 2.5 cents a share.... crazy low price to exit Lind Partner stitch up but buying time for us to complete trials to enter partnership, takeover, whatever ...
September 2015, need another capital raising and after talking about an early partnering opportunity for Invion 103 now for well over 18 months, the company should change its corporate presentation to reflect it's not early but long overdue.
Nonetheless, like many, I remain positive but the IVX itch on my neck is becoming very irritable.